DropsMRP Under Process
Official PMBI MRP is being updated for catalog code 1883.
Locate Jan Aushadhi KendraClinical Overview
Gentamicin 0.3% w/v + Dexamethasone 0.1% w/v Eye Drops is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Instill prescribed drops into the conjunctival sac of the eye or auditory canal of the ear as directed by your physician under aseptic technique. Maintain dropper sterility.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Transient stinging, burning, local irritation. Rare/Severe: Hypersensitivity and localized epithelial toxicity.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
For external ophthalmic or otic use only. Discontinue if redness, swelling, or pain worsens. Keep dropper tip untouched.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or ophthalmic treatment recommendations. Always consult a registered ophthalmologist or ENT specialist before initiating, changing, or instilling any ophthalmic or otic medication.
Gentamicin Sulphate Injection 80 mg per 2ml
Gentamicin Sulphate is a bactericidal aminoglycoside antibiotic produced by Micromonospora purpurea. It acts by binding to the 30S bacterial ribosome, disrupting protein elongation and destabilizing bacterial cell membranes. Used in the management of severe systemic infections, including sepsis, complicated intra-abdominal infections, pyelonephritis, endocarditis (in synergy with beta-lactams), and pelvic inflammatory disease caused by susceptible aerobic Gram-negative pathogens.
Beclomethasone Dipropionate 0.025%, Clotrimazole 1% and Gentamicin Sulphate 0.1% Cream
Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.
Dexamethasone Tablets 0.5 mg
Dexamethasone (Tablets IP 0.5mg) is a long-acting synthetic fluorinated corticosteroid with 25 to 30 times the anti-inflammatory potency of hydrocortisone and virtually no mineralocorticoid (salt-retaining) activity, on the WHO Model List of Essential Medicines. It possesses exceptional tissue penetration including across the blood-brain barrier and placenta. Indicated for cerebral edema (brain tumors, trauma), severe COVID-19 with hypoxemia, croup, antenatal acceleration of fetal lung maturation in threatened preterm birth (24-34 weeks gestation), chemotherapy-induced nausea/vomiting, and severe allergic/anaphylactic crises.
Dexamethasone Injection 4mg per ml
Dexamethasone (Injection IP 4mg/ml) is a long-acting synthetic fluorinated corticosteroid with 25 to 30 times the anti-inflammatory potency of hydrocortisone and virtually no mineralocorticoid (salt-retaining) activity, on the WHO Model List of Essential Medicines. It possesses exceptional tissue penetration including across the blood-brain barrier and placenta. Indicated for cerebral edema (brain tumors, trauma), severe COVID-19 with hypoxemia, croup, antenatal acceleration of fetal lung maturation in threatened preterm birth (24-34 weeks gestation), chemotherapy-induced nausea/vomiting, and severe allergic/anaphylactic crises.